What is PGNY's current stock price?

PGNY (Progyny, Inc.) is currently trading at $25.41 with a market cap of $1.99B.

What sector is Progyny, Inc. in?

Progyny, Inc. (PGNY) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.

Is PGNY a good stock to buy?

Analysts have a Buy consensus on PGNY with a price target of $30.33. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

PGNY Progyny, Inc.

Healthcare

$25.41+0.00%OpenMarket Cap: $1.99B

As of 2026-05-26

Valuation

View Details

P/E (TTM)

24.02

PEG

3.12

P/B

4.58

P/S

1.51

EV/EBITDA

17.05

DCF Value

$23.80

FCF Yield

9.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

24.1%

Operating Margin

7.5%

Net Margin

5.2%

ROE

13.3%

ROA

9.7%

ROIC

13.2%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$328.5M	$24.2M	$—
Q4 null	$318.4M	$12.5M	$—
FY null	$1.29B	$58.5M	$—
Q3 null	$313.3M	$13.9M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$30.33

Target (Median)

$30.00

Target Range

$27.00 - $35.00

2 Strong Buy8 Buy2 Hold0 Sell0 Strong Sell

Canaccord GenuityBuy

2026-05-19

BarclaysOverweight

2026-05-18

Truist SecuritiesBuy

2026-05-11

CitizensMarket Outperform

2026-05-11

BarclaysOverweight

2026-03-20

Trading Activity

Insider Trades

View All

Livingston Mark S.officer: CHIEF FINANCIAL OFFICER

SellThu May 21

Cummings Melissa Bofficer: Chief Operating Officer

SellThu May 21

Cummings Melissa Bofficer: Chief Operating Officer

SellThu Apr 16

Clapp Geoffreyofficer: Chief Product Officer

SellThu Mar 19

Swartz Allisonofficer: EVP, GC

SellFri Mar 06

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

Exchange

—

Beta

0.91

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Peers

PHR

SEM

TXG